Wang, Guihua (1961) 王桂華
Main board
| Organisation | Position | From | Until | Total Return |
CAGR total return |
CAGR relative return |
||
|---|---|---|---|---|---|---|---|---|
| 1 | Beijing Tongrentang Company Limited | Ind DirIndependent Director | 2021-06 | |||||
| 2 | * | CHINA SHINEWAY PHARMACEUTICAL GROUP LIMITED | INEDIndependent Non-Executive Director | 2023-04-01 | 23.65% | 22.24% | 41.24% | |
| 3 | Chongqing Huasen Pharmaceutical Co., Ltd. | Ind DirIndependent Director | 2015-09 | 2021-09 | ||||
| 4 | Guangdong Taiantang Pharmaceutical Co., Ltd. | Ind DirIndependent Director | 2016-05 | 2023-01 | ||||
| 5 | Hainan Huluwa Pharmaceutical Group Co., Ltd. | Ind DirIndependent Director | 2018-11 | |||||
| 6 | Henan Lingrui Pharmaceutical Company Limited | Ind DirIndependent Director | 2016-03 | 2019-03 | ||||
| 7 | Hunan Fangsheng Pharmaceutical Co., Ltd. | Ind DirIndependent Director | 2015-06 | 2017-04 | ||||
| 8 | Inner Mongolia Furui Medical Technology Co., Ltd. | Ind DirIndependent Director | 2016-04 | 2019-04 | ||||
| 9 | Shandong Wohua Pharmaceutical Co., Ltd. | Ind DirIndependent Director | 2014-06 | 2019-02 | ||||
| DirDirector | 2019-02 | 2022-02 | ||||||
| Average | 22.24% | 41.24% |
Some data are hidden to fit your display. Rotate?
Total returns are measured from the latest of the start date, the appointment date and 3-Jan-1994 until the earliest of the end date, the resignation/removal date and the last trading date. CAGR is the annualised return and is not shown for periods under 180 days. Relative returns are to the Tracker Fund of HK (2800), starting from the latest of 12-Nov-1999, the appointment date and the chosen start date.
* = is or was HK primary-listed
Sign up for our free newsletter
Recommend Webb-site to a friend
Copyright & disclaimer, Privacy policy